Search

Experience the words and artwork of three patients who found hope and healing through MSK art programs.

… Thursday, January 24, 2019 Summary Three patients share how MSK’s art-making programs helped them express their emotions and heal during their cancer treatment. Making art can be a powerful form of therapy. It can be especially beneficial for people with cancer, helping them to cope better with physical

… Monday, October 6, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Maria Jasin Awarded the 2025 Peral Meister Greengard Prize Maria Jasin Maria Jasin, PhD , developmental biologist and William E. Snee Chair, has been  selected as the 2025 recipient

Along with their alluring beauty, minerals — like scientific ideas — open a window onto the history of the world, Dr. Massagué says.

… Friday, October 11, 2024 Joan Massagué, PhD , has been featured in the pages of The New Yorker twice. Once for each of his two passions: cancer biology and mineral collecting. In 2017, his  groundbreaking work on metastasis was highlighted by Pulitzer Prize-winning author and physician-scientist  Siddhartha

Feelings of guilt are common after surviving cancer, but MSK offers many support services that can help patients feel better.

… Wednesday, June 29, 2016 Summary Difficulty coping with the emotional toll of a cancer diagnosis can continue long after treatments are over. Guilt is a common feeling experienced by cancer survivors, but there are ways to address it. Highlights Guilt is a normal emotion after cancer, and there are many

Dr. Maria Jasin, whose fundamental research on repair of damaged DNA in cells has transformed our understanding of cancers linked to inherited gene mutations, was selected as the 2025 recipient of the Pearl Meister Greengard Prize — the preeminent international award recognizing outstanding women scientists.

… Thursday, September 11, 2025 Developmental biologist Maria Jasin, PhD , whose fundamental research on repair of damaged DNA in cells has transformed our understanding of cancers linked to inherited gene mutations, has been selected as the 2025 recipient of the Pearl Meister Greengard Prize . Awarded

Meet Memorial Sloan Kettering senior vice president Cynthia McCollum, who led MSK's response to the COVID-19 pandemic.

… Friday, April 2, 2021 Summary Cynthia McCollum , Senior Vice President, Hospital Administration, has served as the Incident Commander for the Hospital Incident Command System (HICS), overseeing MSK’s response to the COVID-19 pandemic, since April 2020. Given her wide-ranging interests and experiences

New MSK research measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and shows how a universal opt-out approach could help more cancer patients quit smoking.

… Friday, May 10, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.

… Monday, September 16, 2013 Summary In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs. Derek Tan , a chemist and a member of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program , is searching

Memorial Sloan Kettering Cancer Center (MSK) announced that Cardinale Smith, MD, PhD, has joined the institution as the inaugural Chief Medical Officer (CMO).

… Thursday, May 29, 2025 Memorial Sloan Kettering Cancer Center (MSK) announced that  Cardinale Smith, MD, PhD , has joined the institution as the inaugural Chief Medical Officer (CMO). In this role, Dr. Smith oversees clinical quality, patient safety, regulatory compliance, and works with faculty and

Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy in patients with head and neck cancers, according to results of an MSK-led clinical trial presented today at the 2025 American Society for Radiation Oncology Annual Meeting.

… Monday, September 29, 2025 Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy (intensity modulated radiotherapy, IMRT) in patients with head and neck cancers, according to results of an MSK-led clinical trial presented